Rapid resolution of erythrodermic atopic dermatitis with upadacitinib: A case report

被引：0

作者：

Saad, Mysa ^{[1
]}

Guirguis, Marina ^{[1
]}

Hamm, Camille ^{[2
]}

Bose, Reetesh ^{[1
,2
]}

机构：

[1] Univ Ottawa, Fac Med, Roger Guindon Hall, Ottawa, ON, Canada

[2] Ottawa Hosp, Div Dermatol, 737 Parkdale Ave, Ottawa, ON K1Y 4M9, Canada

来源：

SAGE OPEN MEDICAL CASE REPORTS | 2024年 / 12卷

关键词：

Erythrodermic atopic dermatitis; upadacitinib; JAK inhibitor; dupilumab; prednisone; DUPILUMAB; SAFETY;

D O I：

10.1177/2050313X241260497

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atopic dermatitis is a chronic inflammatory skin disease that may progress to erythroderma in severe cases. Biologic agents such as dupilumab have recently become the mainstay of systemic treatment for moderate-to-severe cases, yet many patients remain refractory to therapy. Here, we present a case of erythrodermic atopic dermatitis, resistant to prednisone and dupilumab, with remarkably rapid achievement of remission following treatment with upadacitinib, an oral selective Janus kinase 1 inhibitor.

引用

页数：3

共 50 条

[41] Congenital erythrodermic psoriasis with atopic dermatitis: An example of immunogenetic spinoff
Parimalam, K.
Thomas, Jayakar
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2013, 56 (01) : 72 - U81
[42] Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report
TAKEOKA, Shintaro
KAMATA, Masahiro
YOKOI, Ikumi
TAKEHARA, Aya
TADA, Yayoi
ACTA DERMATO-VENEREOLOGICA, 2021, 101
[43] CalcipotriolExacerbation of atopic dermatitis in a child: case report
Reactions Weekly, 2013, 1472 (1) : 11 - 11
[44] MesalazinePhotosensitivity and exacerbation of atopic dermatitis: case report
Reactions Weekly, 2011, 1359 (1) : 26 - 26
[45] Food allergy and atopic dermatitis: a case report
Navarro, Guerrero M.
Abellan, Aleman A.
Blanco, Pascual J.
Merida, Fernandez C.
ALLERGY, 2008, 63 : 322 - 322
[46] OMALIZUMAB FOR SEVERE ATOPIC DERMATITIS: A CASE REPORT
Fasick, G. Coppola
Ramos, C.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S121 - S121
[47] OmalizumabSevere exacerbation of atopic dermatitis: case report
Reactions Weekly, 2018, 1712 (1) : 413 - 413
[48] Effectiveness of upadacitinib in Japanese patients with prurigo-type atopic dermatitis: Four cases report
Kosaka, Keiji
Uchiyama, Akihiko
Ishikawa, Mai
Motegi, Sei-ichiro
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (06) : 262 - 263
[49] Immediate exacerbation of atopic dermatitis after switching from upadacitinib to dupilumab: A report of two cases
Ito, Makoto
Kamata, Masahiro
Uchida, Hideaki
Egawa, Shota
Fukaya, Saki
Hayashi, Kotaro
Fukuyasu, Atsuko
Tanaka, Takamitsu
Ishikawa, Takeko
Tada, Yayoi
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (05) : 168 - 171
[50] Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib
De Luca, E.
Gori, N.
Chiricozzi, A.
Di Stefani, A.
Peris, K.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (07) : 3068 - 3069

← 1 2 3 4 5 →